Caenorhabditis elegans in anthelmintic research - Old model, new perspectives

Area of Science:

• * Nematology
• * Pharmacology
• * Drug Discovery

Background:

• * The free-living nematode Caenorhabditis elegans has been a cornerstone in anthelmintic research for over 40 years.
• * Genetic screens and heterologous expression in C. elegans have identified molecular targets for major anthelmintic drug classes.
• * Despite insights into common mechanisms, a breakthrough in parasitic nematode control remains elusive due to significant nematode diversity.

Purpose of the Study:

• * To review milestones and challenges of using C. elegans in anthelmintic drug target identification and discovery.
• * To summarize the identification of anthelmintic resistance mechanisms.
• * To present new perspectives and strategies for future anthelmintic research leveraging C. elegans progress.

Main Methods:

• * Review of classic genetic screens in C. elegans for drug target identification.
• * Analysis of heterologous expression studies in C. elegans for drug target characterization.
• * Examination of literature on anthelmintic resistance mechanisms in nematodes.
• * Synthesis of current research progress and future strategies in C. elegans for anthelmintic development.

Main Results:

• * C. elegans has been instrumental in identifying targets for existing anthelmintic drug classes.
• * The model's limitations in recapitulating the diversity of parasitic nematodes hinder the development of broad-spectrum drugs.
• * Increasing evidence points to the need for strategies beyond single-species models to address nematode diversity and resistance.

Conclusions:

• * While C. elegans has significantly contributed to understanding anthelmintic targets, it has not led to a breakthrough in broad-spectrum treatment.
• * The vast diversity within the phylum Nematoda presents a major challenge for developing effective, wide-ranging anthelmintics.
• * Future anthelmintic research must incorporate new perspectives and strategies, building upon C. elegans advancements while acknowledging its limitations.